Cargando…
Prevalence of malignant hyperthermia diagnosis in obstetric patients in the United States, 2003 to 2014
BACKGROUND: The cost-benefit of stocking dantrolene in maternity units for treating malignant hyperthermia (MH) has been recently questioned because of the low incidence of MH crisis in the general population and the low utilization of general anesthesia in obstetrics. However, no study has examined...
Autores principales: | Guglielminotti, Jean, Rosenberg, Henry, Li, Guohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971943/ https://www.ncbi.nlm.nih.gov/pubmed/31959119 http://dx.doi.org/10.1186/s12871-020-0934-0 |
Ejemplares similares
-
Accuracy of the diagnosis of malignant hyperthermia in hospital discharge records
por: Pinyavat, Teeda, et al.
Publicado: (2014) -
Malignant hyperthermia
por: Rosenberg, Henry, et al.
Publicado: (2007) -
Hypothermia-Related Deaths — Wisconsin, 2014, and United States, 2003–2013
por: Meiman, Jon, et al.
Publicado: (2015) -
Malignant hyperthermia: a review
por: Rosenberg, Henry, et al.
Publicado: (2015) -
Geographic Variation in Pediatric Cancer Incidence — United States, 2003–2014
por: Siegel, David A., et al.
Publicado: (2018)